Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando López-Ríos

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinomaCarlos Gómez-Martín, Angel Concha, José María Corominas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2009
Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)Joan Albanell, Xavier Andreu, María José Calasanz, et al.
The Oncologist|March 29, 2011
External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment roundsEllen Bellon, Marjolijn J L Ligtenberg, Sabine Tejpar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2011
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working groupErik Thunnissen, Keith M Kerr, Felix J F Herth, et al.
Scientific Reports|October 15, 2024
Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathologyIrene Carretero-Barrio, Lara Pijuan, Adrián Illarramendi, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Archives of Pathology & Laboratory Medicine|December 29, 2012
Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin testJosef Rüschoff, Keith M Kerr, Hans J Grote, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinomaCarlos Gómez-Martín, Angel Concha, José María Corominas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2009
Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)Joan Albanell, Xavier Andreu, María José Calasanz, et al.
The Oncologist|March 29, 2011
External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment roundsEllen Bellon, Marjolijn J L Ligtenberg, Sabine Tejpar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2011
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working groupErik Thunnissen, Keith M Kerr, Felix J F Herth, et al.
Scientific Reports|October 15, 2024
Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathologyIrene Carretero-Barrio, Lara Pijuan, Adrián Illarramendi, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Archives of Pathology & Laboratory Medicine|December 29, 2012
Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin testJosef Rüschoff, Keith M Kerr, Hans J Grote, et al.
Pageof 6